RFC
ONCE

Russell Frank Company’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Russell Frank Company’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-13,484
Closed -$813K – 3095
2015
Q2 		$813K Sell
13,484
-2,127
-14% -$141K ﹤0.01% 2406
2015
Q1 		$1.21M Buy
+15,611
New +$899K ﹤0.01% 2044

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Russell Frank Company's ONCE Position: Q3 2015 in Review

Russell Frank Company sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2015, closing a stake of 13,484 shares — an estimated $813K sold.

Russell Frank Company first reported a position in ONCE in Q1 2015 and held it in 2 quarters. The position peaked at $1.21M in Q1 2015. 90 funds tracked by Wall St. Rank hold ONCE as of Q3 2015.

  • Russell Frank Company reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Russell Frank Company sold 13,484 Spark Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $813K.
  • Russell Frank Company first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
  • Russell Frank Company's Spark Therapeutics, Inc. Common Stock position peaked at $1.21M in Q1 2015.
  • 90 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Russell Frank Company's 13F filing for Q3 2015, filed 23 Oct 2015.